Invesco S&P 500 Equal Weight Health Care ETFRSPH
RSPH
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
2% less funds holding
Funds holding: 187 [Q2] → 184 (-3) [Q3]
3.5% less ownership
Funds ownership: 44.61% [Q2] → 41.11% (-3.5%) [Q3]
7% less capital invested
Capital invested by funds: $420M [Q2] → $391M (-$28.2M) [Q3]
25% less funds holding in top 10
Funds holding in top 10: 4 [Q2] → 3 (-1) [Q3]
42% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 73
Research analyst outlook
We haven’t received any recent analyst ratings for RSPH.
Financial journalist opinion
Neutral
Zacks Investment Research
1 week ago
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a passively managed exchange traded fund launched on 11/01/2006.
Neutral
Zacks Investment Research
1 month ago
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a smart beta exchange traded fund launched on 11/01/2006.
Neutral
Zacks Investment Research
2 months ago
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a passively managed exchange traded fund launched on 11/01/2006.
Neutral
Zacks Investment Research
3 months ago
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
A smart beta exchange traded fund, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) debuted on 11/01/2006, and offers broad exposure to the Health Care ETFs category of the market.
Neutral
Seeking Alpha
3 months ago
RSPH: Outperformance In 2025 Expected
Invesco S&P 500 Equal Weight Health Care ETF's equal-weight strategy should outperform in a lower rate environment, despite its higher expense ratio compared to market-cap weighted ETFs. The healthcare sector faced profit margin compression due to rising wages and inflation, leading to RSPH's underperformance in the past two years. With receding inflation and a weakening job market, healthcare sector earnings are expected to grow strongly by 21.0% in 2025.
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a passively managed exchange traded fund launched on 11/01/2006.
Neutral
Zacks Investment Research
5 months ago
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a smart beta exchange traded fund launched on 11/01/2006.
Neutral
Zacks Investment Research
6 months ago
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on 11/01/2006.
Neutral
ETF Trends
7 months ago
Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
Negative
Seeking Alpha
8 months ago
RSPH: Healthcare Dashboard For May 2024
This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality.
Charts implemented using Lightweight Charts™